| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Low Doses of Nonylphenol Promote Growth of Colon Cancer Cells through Activation of ERK1/2 via G Protein‒Coupled Receptor 30
Ming Xie, Jin-Long Liang, Han-Dong Huang, Mai-Jian Wang, Tao Zhang, Xue-Feng Yang
Cancer Res Treat. 2019;51(4):1620-1631.   Published online May 15, 2019    DOI: https://doi.org/10.4143/crt.2018.340
                           Web of Science 13  Crossref 11
Prognostic Role of Rb, p16, Cyclin D1 Proteins in Soft Tissue Sarcomas
Byoung Yong Shim, Jinyoung Yoo, Yeon-Soo Lee, Young Sun Hong, Hoon-Kyo Kim, Jin-Hyoung Kang
Cancer Res Treat. 2010;42(3):144-150.   Published online September 30, 2010    DOI: https://doi.org/10.4143/crt.2010.42.3.144
                           Crossref 6
Cyclin D1 Overexpression, p16 Loss, and pRb Inactivation Play a Key Role in Pulmonary Carcinogenesis and have a Prognostic Implication for the Long-term Survival in Non-small Cell Lung Carcinoma Patients
Na-Hye Myong
Cancer Res Treat. 2008;40(2):45-52.   Published online June 30, 2008    DOI: https://doi.org/10.4143/crt.2008.40.2.45
                           Crossref 17
The Role of E-cadherin/β-catenin Complex and Cyclin D1 in Head and Neck Squamous Cell Carcinoma
Nam Yong Do, Sung Yong Park, Sung Chul Lim
Cancer Res Treat. 2004;36(1):72-78.   Published online February 29, 2004    DOI: https://doi.org/10.4143/crt.2004.36.1.72
                           Crossref 3
Interrelation of Cyclin D1, Cyclin E, and p27Kip1 Expression on Tissue Arrays of Breast Cancer
Se Hwan Han, Kyeong Mee Park, Byung Noe Bae, Suk Yong Ryu, Ki Hwan Kim, Hong Joo Kim, Young Duck Kim, Hong Yong Kim
Cancer Res Treat. 2002;34(5):388-393.   Published online October 31, 2002    DOI: https://doi.org/10.4143/crt.2002.34.5.388
         Crossref 1
Expression of G1/S Phase Checkpoint Proteins in Breast Carcinoma: Relationship to Clinicopathologic Factors andSurvival Rate
Mi Ja Lee
Cancer Res Treat. 2002;34(4):268-273.   Published online August 31, 2002    DOI: https://doi.org/10.4143/crt.2002.34.4.268
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI